tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding Ag (CH:SANN)
:SANN
Switzerland Market

Santhera Pharmaceuticals Holding (SANN) Income Statement

Compare
0 Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q4 2024), Santhera Pharmaceuticals Holding's total revenue was CHF25.00M, an increase of 1944.40% from the same quarter last year. In Q4, Santhera Pharmaceuticals Holding's net income was CHF-26.71M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 39.12MCHF 103.41MCHF 7.47MCHF -1.59MCHF 15.01M
Gross Profit
CHF 22.96MCHF 100.18MCHF 3.88MCHF -5.36MCHF 4.58M
Operating Expenses
CHF 56.34MCHF 31.34MCHF 55.86MCHF 51.53MCHF 57.65M
Depreciation and Amortization
CHF 5.65MCHF 3.04MCHF 3.65MCHF 3.72MCHF 7.14M
EBITDA
CHF -15.89MCHF 79.17MCHF -46.78MCHF -34.57MCHF -53.43M
Operating Income
CHF -33.38MCHF 68.84MCHF -51.98MCHF -56.89MCHF -53.08M
Other Income/Expenses
CHF -8.28MCHF -14.02MCHF -18.64MCHF 2.17MCHF -14.38M
Pretax Income
CHF -41.66MCHF 54.82MCHF -70.62MCHF -54.72MCHF -67.46M
Net Income
CHF -41.97MCHF 54.78MCHF -71.08MCHF -55.53MCHF -67.66M
Per Share Metrics
Basic EPS
CHF -3.69CHF 5.18CHF -11.67CHF -16.25CHF -50.81
Diluted EPS
CHF -3.69CHF 5.01CHF -11.67CHF -16.25CHF -50.81
Weighted Average Shares Outstanding
11.38M 10.58M 6.09M 3.42M 1.33M
Weighted Average Shares Outstanding (Diluted)
11.38M 10.92M 6.09M 3.42M 1.33M
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis